WallStreetZenWallStreetZen

NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurosense Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alon BennoonChief Executive Officer2026-06-16250,000$0.80
$200.00kBuy
Or EisenbergChief Financial Officer2026-06-16250,000$0.80
$200.00kBuy

1 of 1

NRSN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRSN insiders and whales buy or sell their stock.

NRSN Shareholders

What type of owners hold Neurosense Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alon Bennoon13.93%4,534,233$3.43MInsider
Or Eisenberg4.62%1,504,050$1.14MInsider
Hagit Binder1.60%521,806$395.01kInsider
Ferenc Tracik1.31%428,011$324.00kInsider
Mark Leuchtenberger0.38%122,951$93.07kInsider
Cary J. Claiborne0.31%99,898$75.62kInsider
Christine A. Pellizzari0.31%99,898$75.62kInsider
Yorkville Advisors Global LP0.24%78,000$59.05kInstitution
Revital Mandillevin0.24%76,844$58.17kInsider
Roy Golan0.24%76,844$58.17kInsider

1 of 3

NRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRSN1.17%22.96%Net BuyingNet Buying
NEUP20.40%79.60%Net Buying
SKYE2.23%97.77%Net Selling
EVAX0.37%5.19%
IGC4.33%21.50%Net BuyingNet Buying
View Top Biotech Stocks

Neurosense Therapeutics Stock Ownership FAQ

Who owns Neurosense Therapeutics?

Neurosense Therapeutics (NASDAQ: NRSN) is owned by 1.17% institutional shareholders, 22.96% Neurosense Therapeutics insiders, and 75.88% retail investors. Alon Bennoon is the largest individual Neurosense Therapeutics shareholder, owning 4.53M shares representing 13.93% of the company. Alon Bennoon's Neurosense Therapeutics shares are currently valued at $3.43M.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.